europe
koya979 / shutterstock.com
18 August 2016Big Pharma

European Commission grants authorisation for Cinqaero

Teva  announced today that the European Commission has granted marketing authorisation for Cinqaero (reslizumab) following an efficacy probe.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk